Primaquine phosphate labels and packages: Difference between revisions
Jump to navigation
Jump to search
Created page with "__NOTOC__ {{Primaquine phosphate}} {{CMG}}; {{AE}} {{chetan}} <ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = PRIMAQUINE PHOSPHATE TABLET, FILM ..." |
No edit summary |
||
| Line 3: | Line 3: | ||
{{CMG}}; {{AE}} {{chetan}} | {{CMG}}; {{AE}} {{chetan}} | ||
PRINCIPAL DISPLAY PANEL - 26.3 mg Tablet Bottle Label | |||
P-425 NDC 0024-1596-01 100 tablets | |||
Primaquine phosphate Tablets, USP | |||
26.3 mg (=15 mg base) | |||
Usual Dosage: See package insert. | |||
Dispense in tight, light-resistant container as | |||
defined in the USP/NF. Store at 25° C (77° F); | |||
excursions permitted to 15° C - 30° C (59° F - 86° F) | |||
[see USP Controlled Room Temperature]. | |||
NSN 6505-01-348-2465 | |||
Rx only | |||
SANOFI<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = PRIMAQUINE PHOSPHATE TABLET, FILM COATED [SANOFI-AVENTIS U.S. LLC] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1bfbf4ae-81b8-4160-a00d-6322aadd4b59 | publisher = | date = | accessdate = }}</ref> | |||
==References== | ==References== | ||
Latest revision as of 05:33, 8 January 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Chetan Lokhande, M.B.B.S [2]
PRINCIPAL DISPLAY PANEL - 26.3 mg Tablet Bottle Label
P-425 NDC 0024-1596-01 100 tablets Primaquine phosphate Tablets, USP 26.3 mg (=15 mg base)
Usual Dosage: See package insert. Dispense in tight, light-resistant container as defined in the USP/NF. Store at 25° C (77° F); excursions permitted to 15° C - 30° C (59° F - 86° F) [see USP Controlled Room Temperature].
NSN 6505-01-348-2465 Rx only
SANOFI[1]
References
Adapted from the FDA Package Insert.